Data compiled by Redley Lamar · ChainSifter Intelligence
2Suppliers
8Customers
2Debt Items
20Related Chains
Source-Backed Evidence Depth
CG Oncology, Inc. (CGON) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
13Total relationships
2Distinct source URLs
6High confidence
0.770Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
CG Oncology, Inc. Suppliers
Ticker
Name
Confidence
Evidence
BIOVIRE
BIOVIRE
92%
Prior to becoming a majority-owned subsidiary, Biovire was a vendor to the Company and continues to provide clinical supply of cretostimogene used in the Company’s clinical trials.
Reciprocal relationship from AURA graph: rts of such third parties, which may not be successful. Further, if we enter into arrangements with third parties to perform sales and marketing services, our…
CG Oncology, Inc. Customers
Ticker
Name
Confidence
Evidence
KISSEI
KISSEI
90%
The Company evaluated the Kissei Territory specific license and related activities under ASC 606, as these transactions are considered transactions with a customer, and identified two material promis…
SP-HEALTHCARE-SPV-I-LLC
SP-HEALTHCARE-SPV-I-LLC
85%
Healthcare, LLC (SafeGuard), purchased a $26.8 million convertible note, including accrued interest, from SP Healthcare SPV I, LLC (the SPV). The SPV used the proceeds from the Note to invest and acq…
Reciprocal relationship from BDRX graph: Reciprocal relationship from CGON graph: Reciprocal relationship from BDRX graph: Reciprocal relationship from CGON graph: Reciprocal relationship from BDRX g…
Reciprocal relationship from TOVX graph: Reciprocal relationship from CGON graph: Reciprocal relationship from TOVX graph: prescribe legally available drugs for off-label uses, drugs may be marketed …
HEALTHCARE-LLC
HEALTHCARE-LLC
62%
Healthcare, LLC (SafeGuard), purchased a $26.8 million convertible note, including accrued interest, from SP Healthcare SPV I, LLC (the SPV). The SPV used the proceeds from the Note to invest and acq…
KISSEI-PHARMACEUTICAL-CO-LTD
KISSEI-PHARMACEUTICAL-CO-LTD
62%
nt) and obtained control of both the SPV and Biovire. As a result of this change in control, the operations of Biovire were consolidated as of the effective date of the conversion. We believe, based …
LEPU-BIOTECH-CO-LTD
LEPU-BIOTECH-CO-LTD
62%
nt) and obtained control of both the SPV and Biovire. As a result of this change in control, the operations of Biovire were consolidated as of the effective date of the conversion. We believe, based …
SAFEGUARD-HEALTHCARE-LLC
SAFEGUARD-HEALTHCARE-LLC
62%
ting cretostimogene in combination with gemcitabine in both the high-risk BCG-exposed and BCG-unresponsive population. Based on internal research derived from NIH SEER database, secondary claims data…
CG Oncology, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
CGON-DEBT
Debt stack $3.0M
90%
Market cache reports total debt of $3.0M.
CGON-DEBT-8613
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2024-12-31.
CG Oncology, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for CG Oncology, Inc..
CG Oncology, Inc. Ownership
Holder
Name
Confidence
Evidence
CGON-OWNER-RTW-INVESTMENTS-LP
RTW INVESTMENTS, LP
90%
13F overlay lists RTW INVESTMENTS, LP as top holder; 239 tracked holders.
